Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




CVAT, Grass Roots Research Initiates Coverage With $2.04 Price Target

Dr. Stock Pick (November 20th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_______________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_______________________________________

Friday November 20, 2009

DrStockPick.com Stock Report!

CVAT, Cavitation Technologies Inc, CVAT.OB

**************************************************************

Grass Roots Research Initiates Coverage With $2.04 Price Target

LOS ANGELES, (CRWENEWSWIRE Nov 20, 2009) — Cavitation Technologies, Inc. (CTI) (OTC Bulletin Board: CVAT; Berlin: WTC) is pleased to announce a research report has been issued on the Company by Grass Roots Research and Distribution Inc., Wall Street’s leading independent research firm, with a “BUY” recommendation and a $2.04 long term price target.

To view full report please paste the following link to your browser: www.grassrootsrd.com/Reports/cavitation_technologies.pdf

Grass Roots Research and Distribution, Inc., led by D. Paul Cohen, is one of

...

Lucas Energy Reports Second Fiscal Quarter 2009-2010 Results, Turns EBITDA Positive

Stuart Smith (November 17th, 2009) Writes:

HOUSTON, Nov. 16, 2009 (GLOBE NEWSWIRE) — Lucas Energy, Inc. (NYSE Amex:LEI), an independent oil and gas company (the “Company”) based in Houston, Texas reports the financial results from operations for second quarter of fiscal year 2009-2010.

For the second quarter fiscal year 2009-2010, the Company reports:

Revenues for the quarter ended September 30, 2009 were $414,218 as compared to $441,464 in the first fiscal quarter of year 2009-2010. Lower oil revenues in the current quarter were due primarily to lower oil sales (-20%) partially offset with higher prices realized from oil sales (+19%) in the second fiscal quarter. The reduction in oil sales was due to wells that were offline for workovers and chemical treatments in preparation for production increases as crude oil prices remain high EBITDA from oil and gas operations was $6,359 for the three months ended September 30, 2009, as compared to negative EBITDA totaling $(248,605) ...

Axion Power International, Inc. (AXPW.OB) Reports 2009 Third Quarter, Nine-Month Results

QualityStocks (November 16th, 2009) Writes:

Axion Power International Inc. is the industry leader in the field of lead-acid-carbon energy storage technologies. The company’s new PbCA batteries won the prestigious Frost & Sullivan Technology Award for North America in the field of lead-acid batteries.

The company today reported results for its third quarter and nine months ended September 30, 2009. Sales for the third quarter were $962,833 versus only $149,441 in the 3rd quarter last year, while sales for the first nine months of 2009 were $1.6 million versus only $541,298 for the first nine months of 2009. Axion did show a loss for the first nine months of 2009 totaling $23.5 million, however, over $13.5 million of that total was due to SEC mandated changes on certain derivative securities.

During the third quarter, the company completed an initial phase in its four-year global supply agreement with Exide Technologies. Axion will supply PbCA batteries and other Axion

...

Zimmer to Sell Notes – Analyst Blog

Zacks Market Commentaries (November 13th, 2009) Writes:
Zimmer Holdings, Inc. (ZMH) recently decided to raise $1 billion by selling its senior unsecured notes in an underwritten public offering in two separate transactions. The transactions involve selling $500.0 million of 4.625% notes due 2019 and $500.0 million of 5.75% notes due 2039. The public offering is expected to close on Nov 17, 2009.   Zimmer has already filed an automatic shelf registration statement on Form S-3 with the Securities and Exchange Commission for the public offer. Citigroup Global Markets Inc., a division of Citigroup, Inc. (C); Banc of America Securities LLC, a division of Bank of America Corp. (BAC); and J.P. Morgan Securities Inc., a division of JPMorgan Chase & Co. (JPM) are the active joint book-running managers of the offering. The offer will be made to the public through the prospectus.   The 2019 notes yield 118 basis points above the Treasury ...

QuoteMedia Reports Third Quarter Results

Stuart Smith (November 13th, 2009) Writes:

Nov. 13, 2009 (Business Wire) — QuoteMedia, Inc. (OTCBB: QMCI), a leading provider of market data and financial applications, announced financial results for the three and nine months ended September 30, 2009. These results reflect a 1% increase in third quarter revenue, to $1,910,884 from $1,888,279 in the comparative period in 2008. Revenue for the nine months ended September 30, 2009 increased 7%, to $5,658,444 from $5,300,350 in the comparative period in 2008.

“As forecasted, the global recession moderated QuoteMedia’s revenue growth during the first three quarters of 2009,” says Keith Guelpa, President of QuoteMedia, Inc. “The downturn, however, has presented opportunities as the added pressure on financial sector firms to find more efficient and cost effective solutions to their data and technology needs has opened many new doors for QuoteMedia’s offerings. While we have suffered the loss of some smaller clients who have shrunk or ceased operations as

...

CEPH, PWRM, DrStockPick.com Stock Report! Cephalon Inc. and Power 3 Medical Products Inc.

Dr. Stock Pick (November 13th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

Friday November 13, 2009

DrStockPick.com Stock Report!

CEPH, PWRM

**************************************************************

CEPH, Cephalon Inc.

CEPH engages in the discovery, development, and commercialization of products for central nervous system, inflammatory disease, pain, and oncology therapeutic areas.

According to a Securities and Exchange Commission filing yesterday, CEPH will give Barr Pharmaceuticals Inc. (which now is part of Israel-based Teva Pharmaceutical Industries) a license to sell a generic version of the pain drug Fentora in 2018 as part of a patent lawsuit settlement.

More about CEPH at www.cephalon.com

**************************************************************

PWRM, Power 3 Medical Products Inc, PWRM.OB

PWRM is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer

...
Tags for this Post:
advertisement services, ALS, Barr Pharmaceuticals Inc, Beijing, Breast Cancer, broker, cancer, Cephalon Inc., Chair and Keynote Speaker, chief scientific officer, China, Congress, Crown Equity Holdings Inc.;, diagnostic tests, Dr Stock Pick, equity trader, Fda, Fentora, Houston, inflammatory disease, International Congress, Investing Lessons, Ira Goldknopf, israel, neurodegenerative disease;, pain, Power 3 Medical Products Inc., president, professional investment analyst and consultant, PWRM, Securities And Exchange Commission, stock featured on our site;, Stock Pick, Stocks to Watch, Teva Pharmaceutical Industries;, Texas, USD, www.BestOTC.com, www.cephalon.com, www.crowntradingsystems.com, www.crwenews.com, www.drstockpick.com, www.PennyOmega.com, www.power3medical.com, www.stock-ir.com, www.stock-pr.com

Zacks Analyst Blog Highlights: Sun Microsystems, Inc., Oracle Corp., International Business Machines, Hewlett-Packard and Microsoft – Press Releases

Zacks Market Commentaries (November 10th, 2009) Writes:

For Immediate Release

Chicago, IL – November 10, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Sun Microsystems, Inc. (JAVA), Oracle Corp. (ORCL), International Business Machines (IBM), Hewlett-Packard (HPQ) and Microsoft (MSFT).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Monday’s Analyst Blog:

JAVA Earnings Beat, Sales Lag

Sun Microsystems, Inc. (JAVA) reported results for the first quarter of fiscal 2010 in an SEC filing. Lower operating expenses and higher gross margin helped the company lower its first quarter GAAP loss to $120 million, or 16 cents per share from

...

Sun’s Earnings Beat, Sales Lag – Analyst Blog

Zacks Market Commentaries (November 9th, 2009) Writes:
Sun Microsystems, Inc. (JAVA) reported results for the first quarter of fiscal 2010 in an SEC filing. Lower operating expenses and higher gross margin helped the company lower its first quarter GAAP loss to $120 million, or 16 cents per share from a loss of $1.68 billion or $2.24 per share reported in the year-ago period and beating the Zacks Consensus estimate of a loss of 23 cents per share.  Earnings on a non-GAAP basis (excluding one-time items) rose to 2 cents per share in the quarter from a net loss of 8 cents per share in the year-ago period. Gross margin improved to 43.4% from 40.2% a year ago. Operating expenses were down 62.3% year over year, as a result of which operating margin improved to -4.5% from -55.2% in the year-ago quarter.  However, total revenue fell 25% to $2.24 billion, with both Products and ...

“BUY” Recommendation to CVAT by One of Wall Street’s ELITE Independent Research Firms with a $2.04 long term price target.. DrStockPick.com Watch List! for Monday November 9, 2009, Cavitation Technologies Inc., CVAT.OB

Dr. Stock Pick (November 8th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

DrStockPick.com Watch List!

My Big Pick for Monday November 9, 2009 is:

**************************************************************

CVAT, Cavitation Technologies Inc., CVAT.OB

A research report has been issued on CVAT by Grass Roots Research and Distribution Inc., Wall Street’s leading independent research firm, with a “BUY” recommendation and a $2.04 long term price target.

Grass Roots Research and Distribution, Inc., led by D. Paul Cohen, is one of Wall Street’s ELITE Independent Research Firms. As founder of Bear Stearns Western Regional Offices, Paul Cohen was one of the original 12 Dirty Dozen analysts, regarded by many to be the top 12

...

“BUY” Recommendation to CVAT by One of Wall Street’s ELITE Independent Research Firms with 430% Over Its Last Trade Price Target. DrStockPick.com Watch List! for Monday November 9, 2009, Cavitation Technologies Inc., CVAT.OB

Dr. Stock Pick (November 8th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

DrStockPick.com Watch List!

My Big Pick for Monday November 9, 2009 is:

**************************************************************

CVAT, Cavitation Technologies Inc., CVAT.OB

A research report has been issued on CVAT by Grass Roots Research and Distribution Inc., Wall Street’s leading independent research firm, with a “BUY” recommendation and a $2.04 long term price target.

Grass Roots Research and Distribution, Inc., led by D. Paul Cohen, is one of Wall Street’s ELITE Independent Research Firms. As founder of Bear Stearns Western Regional Offices, Paul Cohen was one of the original 12 Dirty Dozen analysts, regarded by many to

...

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.